Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Androl ; 26(2): 258-63, 2005.
Article in English | MEDLINE | ID: mdl-15713832

ABSTRACT

Several studies suggest that nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) modulate testicular function. In this study, we examined the expression of cGMP-dependent protein kinase G-I (PKG-I), and cyclic nucleotide-gated channel 1 (CNG-1), 2 known mediators of cGMP action, and the expression of soluble guanylyl cyclase (sGC) subunits in the rat testis. Immunohistochemical analysis revealed that the alpha subunit of sGC was expressed in the blood vessels and Leydig cells of adult rat testes. In addition, the sGC alpha subunit was observed in the acrosomal structures of spermatids undergoing the middle and later stages of spermiogenesis, but not in mature spermatozoa. Similar localization and expression patterns were seen for the sGC beta subunit, indicating coexpression of the sGC subunits. PKG-I was expressed in blood vessels and in the acrosomal region of spermatids during the early and middle stages of spermiogenesis but was not observed in Leydig cells or in mature spermatozoa. In contrast to sGC and PKG-I, CNG-1 was expressed only in cytoplasm and the residual bodies of late-stage (17-19) spermatids, with no staining observed in blood vessels and Leydig cells. These results demonstrate that sGC, PKG-I, and CNG-1 are expressed in a stage- and cell-specific manner in the rat testis. The distinct temporal patterns of expression of these components of cGMP signaling pathways suggest different physiological roles for sGC, PKG-I, and CNG-1 in spermiogenesis and steroidogenesis.


Subject(s)
Cyclic GMP-Dependent Protein Kinases/genetics , Gene Expression Regulation , Guanylate Cyclase/genetics , Ion Channels/genetics , Testis/physiology , Animals , Cyclic GMP-Dependent Protein Kinase Type I , Cyclic Nucleotide-Gated Cation Channels , Gene Expression Regulation, Enzymologic , Male , Protein Subunits/genetics , Rats , Rats, Long-Evans , Testis/enzymology , Testis/growth & development
2.
Fertil Steril ; 82 Suppl 3: 1154-9, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15474089

ABSTRACT

OBJECTIVE: To demonstrate the expression of soluble guanylyl cyclase (sGC) alpha and beta subunits in rat granulosa cells and determine the effects sGC activation on levels of cyclic GMP (cGMP), E2, and cAMP. DESIGN: Basic research study. SETTING: University research laboratory. ANIMAL(S): Estrogen-treated immature Sprague-Dawley female rats from which primary cell culture of granulosa cells was obtained. INTERVENTION(S): Functionally immature rat granulosa cells were incubated for 48 hours with media alone, FSH, or FSH plus YC-1, a specific activator of sGC. MAIN OUTCOME MEASURE(S): Expression of sGC alpha and beta subunits was determined by immunoblot analysis. Media concentrations of E2, cAMP, and cGMP were measured by radioimmunoassays. RESULT(S): Immunoblot analysis of granulosa cells revealed the expression of sGC alpha and beta subunits. While cGMP accumulation was low in cells incubated with media alone or with FSH, cotreatment with FSH plus YC-1 increased cGMP levels approximately five-fold. Incubation of cells with FSH stimulated E2 production in a dose-dependent manner. However, cotreatment of cells with FSH plus YC-1 significantly decreased E2 concentrations at all doses of FSH tested. Similarly, while FSH increased cAMP accumulation from granulosa cells, cotreatment with YC-1 markedly inhibited FSH-stimulated cAMP levels. CONCLUSION(S): These findings demonstrate the expression of sGC subunits in rat granulosa cells and indicate that activation of sGC increases cGMP levels, which are associated with inhibition of FSH-stimulated E2 production and cAMP accumulation.


Subject(s)
Cyclic AMP/antagonists & inhibitors , Estradiol/biosynthesis , Granulosa Cells/metabolism , Guanylate Cyclase/metabolism , Animals , Cells, Cultured , Cyclic AMP/metabolism , Cyclic GMP/metabolism , Drug Synergism , Enzyme Activation/physiology , Enzyme Activators/pharmacology , Female , Follicle Stimulating Hormone/pharmacology , Granulosa Cells/enzymology , Guanylate Cyclase/chemistry , Hormones/pharmacology , Immunoblotting , Indazoles/pharmacology , Isoenzymes/chemistry , Isoenzymes/metabolism , Radioimmunoassay , Rats , Rats, Sprague-Dawley , Solubility
3.
Biol Reprod ; 71(3): 845-52, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15163616

ABSTRACT

The present study examined the gonadotropin surge-inducing actions of estradiol (E(2)), both alone and with progesterone (P(4)), in middle-aged, early persistent-estrous (PE) female rats that had become PE within 35 days. In addition, we also assessed the effect of P(4) on the mating-induced gonadotropin surges in these acyclic animals. Early PE rats were ovariectomized and received E(2) implants (Day 0). On Day 4, an s.c. injection of P(4) (0.5 mg/ 100 g body weight) at 1200 h markedly increased plasma P(4) and elicited both LH and FSH surges, whereas vehicle-treated controls displayed no rise in P(4) or gonadotropins. This observation confirms that at middle age, female rats no longer respond to the positive-feedback stimulation of E(2) on gonadotropin surges whenever the estrous cyclicity ceases. As PE continued, such a surge-inducing action of E(2) plus P(4) became diminished after 75 days of PE and disappeared thereafter. When caged with males, vehicle-treated early PE rats display a mating-induced increase in P(4) from the adrenal along with small gonadotropin surges. The amplitude of these mating-induced gonadotropin surges was enhanced by supplementation with exogenous P(4) in early PE rats. Our findings indicate that during the early phase of PE, the surge-inducing action of E(2) and P(4) remains intact but deteriorates as PE continues. Thus, a deficiency in P(4) secretion during aging may contribute to the diminished gonadotropin surge response in the hypothalamic-pituitary axis and the subsequent cessation of estrous cyclicity.


Subject(s)
Aging/physiology , Follicle Stimulating Hormone/blood , Luteinizing Hormone/blood , Neurosecretory Systems/drug effects , Progesterone/pharmacology , Animals , Drug Implants , Estradiol/blood , Estradiol/pharmacology , Female , Follicle Stimulating Hormone/metabolism , Luteinizing Hormone/metabolism , Male , Neurosecretory Systems/physiology , Ovariectomy , Posture , Progesterone/blood , Rats , Rats, Long-Evans , Sexual Behavior, Animal/drug effects
4.
Biol Reprod ; 70(6): 1552-61, 2004 Jun.
Article in English | MEDLINE | ID: mdl-14749300

ABSTRACT

Soluble guanylyl cyclase (sGC) is activated by nitric oxide (NO) and carbon monoxide, resulting in cGMP production. Recent studies indicate that NO and cGMP influence ovarian functions. However, little information is available regarding the ovarian expression of sGC. The present study examined sGC alpha(1) and beta(1) subunit protein levels in the ovary during postnatal development, gonadotropin-induced follicle growth, ovulation, and luteinization as well as in cultured rat granulosa cells. In postnatal rats, sGC alpha(1) subunit immunoreactivity was high in granulosa cells of primordial and primary follicles on Day 5 but low in granulosa cells of larger follicles on Days 10 and 19. Theca cells of developing follicles, but not stromal cells, also demonstrated moderate sGC alpha(1) immunoreactivity. In gonadotropin- treated immature rats, intense sGC alpha(1) subunit staining was similarly observed in granulosa cells of primordial and primary follicles, but such staining was low in granulosa cells of small antral follicles and undetectable in granulosa cells of large antral and preovulatory follicles. Following ovulation, corpora lutea expressed moderate sGC alpha(1) immunoreactivity. Similar ovarian localization and expression patterns were seen for sGC beta(1), indicating regulated coexpression of sGC subunits. Immunoblot analysis revealed no change in total ovarian sGC alpha(1) and beta(1) subunit protein levels during gonadotropin treatment. Similarly, no effect of FSH on sGC subunit protein levels was apparent in cultured granulosa cells. These findings indicate regulated, cell- specific patterns of sGC expression in the ovary and are consistent with roles for cGMP in modulating ovarian functions.


Subject(s)
Guanylate Cyclase/metabolism , Ovary/enzymology , Animals , Animals, Newborn , Cells, Cultured , Female , Gonadotropins/pharmacology , Granulosa Cells/enzymology , Guanylate Cyclase/chemistry , Immunohistochemistry , Luteinization , Ovarian Follicle/drug effects , Ovarian Follicle/enzymology , Ovary/cytology , Ovary/drug effects , Ovulation , Protein Subunits , Rats , Rats, Long-Evans , Rats, Sprague-Dawley , Solubility
5.
Reprod Biomed Online ; 6(1): 15-23, 2003.
Article in English | MEDLINE | ID: mdl-12626139

ABSTRACT

The production of a viable oocyte is dependent upon the critical influences of gonadotrophins on follicular development, granulosa cell maturation, ovulation, and luteinization. While the effects of LH and FSH are due in large part to cyclic AMP-dependent signalling mechanisms, it is clear that a number of other factors modulate the actions of gonadotrophins on the ovary via activation of alternative signalling pathways. In this regard, recent studies indicate that the second messenger guanosine 3',5'-cyclic monophosphate (cGMP) mediates a wide range of influences on the ovary. Nitric oxide (NO) is a major regulator of cGMP production via its action on soluble guanylyl cyclase, while natriuretic peptides activate receptors with intrinsic guanylyl cyclase activities. In addition, other factors known to influence ovarian functions are now recognized to act via NO/cGMP pathways. This report will review these previous findings and present new data demonstrating the inhibitory influence of cGMP on cAMP-stimulated LH receptor expression in cultured granulosa cells.


Subject(s)
Cyclic GMP/metabolism , Ovary/metabolism , Animals , Cell Death/physiology , Estradiol/metabolism , Female , Follicular Atresia/physiology , Guanylate Cyclase/metabolism , Humans , Nitric Oxide/metabolism , Peptide Hormones/metabolism , Receptors, LH/metabolism , Signal Transduction/physiology
6.
Fertil Steril ; 79 Suppl 1: 687-93, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12620478

ABSTRACT

OBJECTIVE: To determine the effects of nitric oxide (NO) and cGMP on inhibin A and inhibin subunit mRNA levels from cultured rat granulosa cells. DESIGN: Basic research study. SETTING: University research laboratory. ANIMAL(S): Primary cell culture of granulosa cells obtained from estrogen-treated, immature Sprague-Dawley female rats. INTERVENTION(S): Functionally immature rat granulosa cells were incubated for 48 hours with media alone; FSH; forskolin; the NO generator DETA/NO; an inhibitor of soluble guanylyl cyclase (ODQ); and/or a cell-permeable cGMP analog. MAIN OUTCOME MEASURE(S): Media concentrations of inhibin A were measured by solid-phase immunosorbent assay. Inhibin alpha and betaA subunit mRNA levels were determined by Northern and slot blot analyses. RESULT(S): Whereas FSH caused a 20-fold increase in inhibin A levels compared with untreated granulosa cells, the NO generator DETA/NO significantly inhibited FSH-stimulated inhibin A concentrations. Similarly, cotreatment with FSH plus dibutyryl cGMP significantly attenuated inhibin A concentrations, compared with those in cells treated with FSH alone. Incubation with forskolin (FSK) stimulated inhibin A levels sevenfold, whereas cotreatment with FSK plus DETA/NO or FSK plus dibutyryl cGMP effectively decreased inhibin A concentrations. The effects of NO on inhibin A levels were not prevented by cotreatment with an inhibitor of soluble guanylyl cyclase. In addition, there was no influence of DETA/NO or dibutyryl cGMP on inhibin subunit mRNA levels. CONCLUSION(S): These findings indicate that NO and cGMP can attenuate inhibin A concentrations through actions at one or more post-FSH receptor sites. These influences may reflect inhibition of inhibin A secretion, rather than gene expression and protein synthesis. In addition, NO decreases inhibin A concentrations through both cGMP-dependent and -independent pathways. These results suggest local roles for NO and cGMP in the regulation of granulosa cell function.


Subject(s)
Dibutyryl Cyclic GMP/pharmacology , Granulosa Cells/drug effects , Inhibins/biosynthesis , Nitric Oxide Donors/pharmacology , RNA, Messenger/metabolism , Animals , Blotting, Northern , Colforsin/pharmacology , Cyclic GMP/antagonists & inhibitors , Cyclic GMP/metabolism , Enzyme Inhibitors/pharmacology , Estradiol/biosynthesis , Estradiol/metabolism , Female , Follicle Stimulating Hormone/pharmacology , Granulosa Cells/metabolism , Inhibins/genetics , Inhibins/metabolism , Nitric Oxide/antagonists & inhibitors , Nitric Oxide/metabolism , Oxadiazoles/pharmacology , Quinoxalines/pharmacology , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL
...